2015
DOI: 10.1134/s1990750815030051
|View full text |Cite
|
Sign up to set email alerts
|

The possibility of using the PlasmaDeepDive™ MRM-panel in clinical diagnostics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…In this case, tandem mass spectra (MS2 spectra) obtained after multidimensional chromatographic separation of a mixture of proteolytic peptides and scans of precursor ions (MS1) and their fragments (MS2) are analyzed [1]. Nevertheless, a significant part of a proteome in biological materials, including proteins present at low concentrations, remains inaccessible for MS/MS analysis [8]. As a consequence, over 70% of all recorded MS2 spectra remain unidentified or contain false identifications [10].…”
Section: Introductionmentioning
confidence: 99%
“…In this case, tandem mass spectra (MS2 spectra) obtained after multidimensional chromatographic separation of a mixture of proteolytic peptides and scans of precursor ions (MS1) and their fragments (MS2) are analyzed [1]. Nevertheless, a significant part of a proteome in biological materials, including proteins present at low concentrations, remains inaccessible for MS/MS analysis [8]. As a consequence, over 70% of all recorded MS2 spectra remain unidentified or contain false identifications [10].…”
Section: Introductionmentioning
confidence: 99%